Evidence map›Paper›PMID 37829179›Full record

ArticleEcology and evolution2023

The contribution of evolvability to the eco-evolutionary dynamics of competing species.

Anuraag Bukkuri, Kenneth J Pienta, Sarah R Amend, Robert H Austin, Emma U Hammarlund, Joel S Brown

Open access · goldAbstract read
In one paragraph

Article in Ecology and evolution, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Cancer Evolvability Determines Therapy Outcomes.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Evolution takes multiple paths to evolvability when facing environmental change.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Anuraag BukkuriCancer Biology and Evolution Program, Department of Integrated Mathematical Oncology Moffitt Cancer Center Tampa Florida USA.ORCID https://orcid.org/0000-0002-3616-626X
Kenneth J PientaThe Brady Urological Institute Johns Hopkins School of Medicine Baltimore Maryland USA.
Sarah R AmendThe Brady Urological Institute Johns Hopkins School of Medicine Baltimore Maryland USA.
Robert H AustinDepartment of Physics Princeton University Princeton New Jersey USA.
Emma U HammarlundTissue Development and Evolution Research Group, Department of Laboratory Medicine Lund University Lund Sweden.
Joel S BrownCancer Biology and Evolution Program, Department of Integrated Mathematical Oncology Moffitt Cancer Center Tampa Florida USA.
Johns Hopkins University · USMoffitt Cancer Center · USLund University · SEPrinceton University · US

Funding

Tumor microvesicle-mediated modulation of the bone microenvironmentP01CA093900 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KELLER, EVAN T · 2004 to 2024
$29.6M
TRANS_NETWORK PROJECTSU54CA143803 · NCI · PRINCETON UNIVERSITY · PI AUSTIN, ROBERT H. · 2009 to 2013
$14.2M
"Research Supplement to Promote Diversity in Health-Related Research", as part of Moffitt PS-OC, "Cancer as a Complex adaptive System"U54CA193489 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI ANDERSON, ALEXANDER ROBERTSON ALLAN, GATENBY, ROBERT A · 2015 to 2020
$12.5M
Eco-evolutionary drivers of clonal dynamics during UV-induced skin carcinogenesis (PQ3)R01CA258089 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI BROWN, JOEL, TSAI, KENNETH Y · 2021 to 2025
$3.1M
Mechanisms That Regulate Dormancy of Disseminated Tumor Cells in the Bone MarrowU54CA163124 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PIENTA, KENNETH J. · 2011 to 2015
$3.0M
Reactive Stroma and Tumor Associated Macrophages in Prostate Cancer ProgressionU01CA143055 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PIENTA, KENNETH J., ROWLEY, DAVID R · 2010 to 2014
$2.7M
NCI NIH HHS P01 CA093900NCI NIH HHS R01 CA258089NCI NIH HHS U01 CA143055NCI NIH HHS U54 CA143803NCI NIH HHS U54 CA163124NCI NIH HHS U54 CA193489
6 · The paper itself

Abstract

Evolvability is the capacity of a population to generate heritable variation that can be acted upon by natural selection. This ability influences the adaptations and fitness of individual organisms. By viewing this capacity as a trait, evolvability is subject to natural selection and thus plays a critical role in eco-evolutionary dynamics. Understanding this role provides insight into how species respond to changes in their environment and how species coexistence can arise and be maintained. Here, we create a G-function model of competing species, each with a different evolvability. We analyze population and strategy (= heritable phenotype) dynamics of the two populations under clade initiation (when species are introduced into a population), evolutionary tracking (constant, small changes in the environment), adaptive radiation (availability of multiple ecological niches), and evolutionary rescue (extreme environmental disturbances). We find that when species are far from an eco-evolutionary equilibrium, faster-evolving species reach higher population sizes, and when species are close to an equilibrium, slower-evolving species are more successful. Frequent, minor environmental changes promote the extinction of species with small population sizes, regardless of their evolvability. When several niches are available for a species to occupy, coexistence is possible, though slower-evolving species perform slightly better than faster-evolving ones due to the well-recognized inherent cost of evolvability. Finally, disrupting the environment at intermediate frequencies can result in coexistence with cyclical population dynamics of species with different rates of evolution.

Indexed as

adaptive dynamicsadaptive radiationeco‐evolutionary dynamicsevolutionary rescueevolutionary trackingevolvabilityG functions

Identifiers

PMID37829179
PMCPMC10565728
OpenAlexW4387574341

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.